Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Oral interferon to enter human trials for MS

March 2, 1999

French investigators describe potent and selective dopamine D3 agonists

March 1, 1999

Potent nAChR receptor agonists with heterocyclic structure patented by Astra

March 1, 1999

CNS compounds from Merck acting on serotonergic system

Feb. 26, 1999

Novel BK channel modulators developed at Bristol-Myers Squibb

Feb. 26, 1999

AutoImmune and Teva to collaborate on oral immune therapies

Feb. 25, 1999

Status updated for Esteve's atypical antipsychotic E-5842

Feb. 25, 1999

New compounds from Pharmacia & Upjohn interfere in the kynurenine metabolic pathway

Feb. 25, 1999

Orphan Medical begins Treatment IND trial of Xyrem in narcolepsy

Feb. 25, 1999

Apollo and AHP to develop estrogen products for Alzheimer's therapy

Feb. 24, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...